The potential utilization of the asymmetric AβPP mRNA amplification in the second stage of AD provides an explanation as to why AD appears to be human-specific (or, at least, species-specific; indeed, it does not occur even in long-living mammals, such as elephants). Here, APP is linked to Alzheimer disease.